US 9,808,430 B2
Compositions and methods relating to resveratrol
Otis L. Blanchard, Austin, TX (US)
Assigned to WILMORE LABS LLC, San Antonio, TX (US)
Filed by Otis L. Blanchard, Austin, TX (US)
Filed on Apr. 20, 2015, as Appl. No. 14/691,320.
Application 14/691,320 is a division of application No. 12/955,810, filed on Nov. 29, 2010, granted, now 9,125,858.
Claims priority of provisional application 61/265,035, filed on Nov. 30, 2009.
Prior Publication US 2015/0216982 A1, Aug. 6, 2015
Int. Cl. A61K 31/05 (2006.01); A61K 31/7004 (2006.01); A61K 47/26 (2006.01); A61K 9/28 (2006.01); A61K 9/00 (2006.01)
CPC A61K 31/05 (2013.01) [A61K 9/006 (2013.01); A61K 9/0056 (2013.01); A61K 47/26 (2013.01)] 25 Claims
 
1. A pharmaceutical composition in lozenge form consisting essentially of resveratrol and a solubilizer, wherein the solubilizer is selected from the group consisting of ribose and deoxyribose, wherein said pharmaceutical composition provides improved serum resveratrol bioavailability in a human subject upon administration compared to serum resveratrol bioavailability in a human subject upon administration of a pharmaceutical composition consisting essentially of resveratrol.